Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_14
Snippet: Between January 2000 and June 2011, the number of non-industry-sponsored vaccine development programs initiated is on par with the number of non-industrysponsored, non-vaccine anti-infective drug development programs initiated (see Figure 1b) . However, the number of non-vaccine drug development programs initiated begin to outpace the number of vaccine development programs after January 2012, and experience a rapid boom between mid-2015 and mid-2.....
Document: Between January 2000 and June 2011, the number of non-industry-sponsored vaccine development programs initiated is on par with the number of non-industrysponsored, non-vaccine anti-infective drug development programs initiated (see Figure 1b) . However, the number of non-vaccine drug development programs initiated begin to outpace the number of vaccine development programs after January 2012, and experience a rapid boom between mid-2015 and mid-2018 before declining rapidly between October 2018 and January 2019. Vaccine Treatment for infectious diseases . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- cc international license and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc international license and non industry: 1, 2, 3, 4
- cc international license and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- drug development and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- drug development and international license: 1, 2, 3
- drug development and non industry: 1, 2, 3, 4, 5, 6, 7, 8
- drug development and non vaccine drug development program: 1
- drug development and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- drug development and vaccine development program: 1, 2, 3
- drug development program and infectious disease: 1, 2, 3
- drug development program and non industry: 1, 2
- drug development program and non vaccine drug development program: 1
- drug development program and vaccine development: 1, 2, 3, 4
- drug development program and vaccine development program: 1, 2
- infectious disease and non industry: 1, 2, 3, 4, 5, 6, 7
- infectious disease and non vaccine drug development program: 1
- infectious disease and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- infectious disease and vaccine development program: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date